Company Quick10K Filing
Burlington Stores
10-Q 2021-05-01 Filed 2021-05-27
10-K 2021-01-30 Filed 2021-03-15
10-Q 2020-10-31 Filed 2020-11-24
10-Q 2020-08-01 Filed 2020-08-27
10-Q 2020-05-02 Filed 2020-05-29
10-K 2020-02-01 Filed 2020-03-13
10-Q 2019-11-02 Filed 2019-11-26
10-Q 2019-08-03 Filed 2019-08-29
10-Q 2019-05-04 Filed 2019-06-03
10-K 2019-02-02 Filed 2019-03-20
10-Q 2018-11-03 Filed 2018-11-28
10-Q 2018-08-04 Filed 2018-08-30
10-Q 2018-05-05 Filed 2018-05-31
10-K 2018-02-03 Filed 2018-03-20
10-Q 2017-10-30 Filed 2017-11-21
10-Q 2017-07-29 Filed 2017-08-24
10-Q 2017-04-29 Filed 2017-05-25
10-K 2017-01-28 Filed 2017-03-16
10-Q 2016-10-29 Filed 2016-11-23
10-Q 2016-07-30 Filed 2016-08-25
10-Q 2016-04-30 Filed 2016-05-26
10-K 2016-01-30 Filed 2016-03-15
10-Q 2015-10-31 Filed 2015-11-24
10-Q 2015-08-01 Filed 2015-08-31
10-Q 2015-05-02 Filed 2015-06-09
10-K 2015-01-31 Filed 2015-03-25
10-Q 2014-11-01 Filed 2014-12-09
10-Q 2014-08-02 Filed 2014-09-11
10-Q 2014-05-03 Filed 2014-06-12
10-K 2014-02-01 Filed 2014-03-31
8-K 2020-11-24
8-K 2020-11-24
8-K 2020-08-27
8-K 2020-07-20
8-K 2020-06-29
8-K 2020-05-28
8-K 2020-05-20
8-K 2020-05-04
8-K 2020-04-13
8-K 2020-04-13
8-K 2020-03-20
8-K 2020-03-17
8-K 2020-03-05
8-K 2020-02-26
8-K 2020-02-10
8-K 2019-11-26
8-K 2019-09-13
8-K 2019-08-29
8-K 2019-05-30
8-K 2019-05-22
8-K 2019-04-23
8-K 2019-03-07
8-K 2018-11-28
8-K 2018-11-02
8-K 2018-10-01
8-K 2018-08-30
8-K 2018-06-29
8-K 2018-06-29
8-K 2018-05-31
8-K 2018-05-16
8-K 2018-03-08
8-K 2018-02-21

Burlington Stores Financials

BURL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2013-10-312014-01-312014-02-012014-05-032014-08-022014-11-012015-01-312015-05-022015-08-012015-10-312016-01-302016-04-302016-07-302016-10-292017-01-282017-04-292017-07-292017-10-302018-02-032018-05-052018-08-042018-11-032019-02-022019-05-042019-08-032019-11-02
Cash32133133692929253527292128303382303348133105111107134127119147
Accounts Receivable55363644445350463949395142604353597972837186599998117
Inventory9027207207087129007898228029347848057458227027267279047537878441,0579548968241,004
PP&E8951,7281,7289089339641,9039679861,0182,0461,0121,0251,0402,1771,0551,0801,1122,3251,1481,1791,2392,5441,2881,3181,375
Assets2,9812,6212,6212,5482,5552,7972,6252,6832,6742,8052,5802,6062,5662,6882,5742,5592,6122,8432,8132,8252,9313,2073,0795,0655,0465,508
Accounts Payable708543543576565767622632590704598594546692640609604765736727762967849708691888
Long-Term Debt1,6921,4051,4051,3671,3731,4241,2501,3171,3511,4141,3051,3521,3531,3051,1301,1541,2781,2961,1271,1361,1581,0929871,1361,083986
Liabilities3,1972,7722,7722,6842,6952,9652,6912,7132,7142,9272,6792,7112,6702,8242,6242,6002,7082,9542,7262,7142,7773,0142,7564,7874,7315,116
Stockholders' Equity-216-150-150-136-140-168-66-30-41-122-99-105-104-135-50-41-96-11187111153193323279315392
Income Statement ($MM)2013-10-312014-01-312014-02-012014-05-032014-08-022014-11-012015-01-312015-05-022015-08-012015-10-312016-01-302016-04-302016-07-302016-10-292017-01-282017-04-292017-07-292017-10-302018-02-032018-05-052018-08-042018-11-032019-02-022019-05-042019-08-032019-11-02
Revenue1,0731,3341,3341,1361,1141,1661,4971,1911,1521,2391,5491,2891,2611,3491,6861,3521,3691,4451,9441,5251,5051,6411,9911,6341,6621,782
Cost of Revenue7787788709179811,1308938779421,1569619701,023
Gross Profit556556627632705814632627699836673692759
R&D
SG&A363374374347350397427378382416422403407451462421437480525468479538517532584
Tax-8113511-2421188956231217652396231175315166923
Net Income-1764641222-349526111599382032126524745241837177184788596
Cash Flow ($MM)2013-10-312014-01-312014-02-012014-05-032014-08-022014-11-012015-01-312015-05-022015-08-012015-10-312016-01-302016-04-302016-07-302016-10-292017-01-282017-04-292017-07-292017-10-302018-02-032018-05-052018-08-042018-11-032019-02-022019-05-042019-08-032019-11-02
Cash Operating-83-8347537214-22211042243073183-28629441493866020954175247
Cash Investing188188-46-49-70-52-43-39-68-45-30-45-62-43-53-54-82-74-58-100-84-80-92
Cash Financing-293-293-65433-1667410-35-1867-25-119-224-2813-52-227-58-11322-103-127